96 related articles for article (PubMed ID: 12013484)
1. Studies on the interactions between the angiotensin converting enzyme inhibitor enalaprilat and calcium antagonists in rats.
Marwood JF
J Hypertens; 1996 Jan; 14(1):123-9. PubMed ID: 12013484
[TBL] [Abstract][Full Text] [Related]
2. Effect of angiotensin II receptor blockade on the interaction between enalaprilat and doxazosin in rat tail arteries.
Marwood JF
Clin Exp Pharmacol Physiol; 1998; 25(7-8):517-21. PubMed ID: 9673422
[TBL] [Abstract][Full Text] [Related]
3. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
Zahradníková A; Minarovic I; Zahradník I
J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
[TBL] [Abstract][Full Text] [Related]
4. Direct angiotensin converting enzyme inhibitor-mediated venodilation.
Zarnke KB; Feldman RD
Clin Pharmacol Ther; 1996 May; 59(5):559-68. PubMed ID: 8646827
[TBL] [Abstract][Full Text] [Related]
5. The interaction between enalaprilat and selected alpha-adrenoceptor antagonists in isolated rat tail arteries.
Marwood JF
Clin Exp Pharmacol Physiol; 1994 May; 21(5):417-25. PubMed ID: 7955551
[TBL] [Abstract][Full Text] [Related]
6. An in vitro study of interactions between doxazosin and enalaprilat at vascular alpha 1-adrenoceptors.
Tierney G; Marwood J; Stokes G
Clin Exp Pharmacol Physiol; 1989 Apr; 16(4):329-32. PubMed ID: 2568203
[TBL] [Abstract][Full Text] [Related]
7. Effects of an alpha-2 adrenoceptor agonist on angiotensin converting enzyme inhibitor-induced hypotension and potentiated allergen-evoked inflammatory skin responses.
Lindgren BR; Grundström N; Andersson RG
J Pharmacol Exp Ther; 1988 Jun; 245(3):932-5. PubMed ID: 2898524
[TBL] [Abstract][Full Text] [Related]
8. Calcium channel blockers induce thymic apoptosis in vivo in rats.
Balakumaran A; Campbell GA; Moslen MT
Toxicol Appl Pharmacol; 1996 Jul; 139(1):122-7. PubMed ID: 8685894
[TBL] [Abstract][Full Text] [Related]
9. A study of the interaction between the hypotensive actions of doxazosin and enalaprilat in anaesthetized rats.
Marwood JF; Tierney G; Stokes GS
J Hypertens; 1992 Mar; 10(3):265-70. PubMed ID: 1315824
[TBL] [Abstract][Full Text] [Related]
10. Interactions between enalaprilat and doxazosin at rat tail artery alpha 1-adrenoceptors.
Marwood J; Tierney G; Stokes G
J Cardiovasc Pharmacol; 1991 Jan; 17(1):1-7. PubMed ID: 1708041
[TBL] [Abstract][Full Text] [Related]
11. Relative contribution of alpha 1-adrenoceptor blocking activity to the hypotensive effect of the novel calcium antagonist monatepil.
Sugimoto T; Hosoki K; Karasawa T
J Cardiovasc Pharmacol; 1995 Jul; 26(1):55-60. PubMed ID: 7564365
[TBL] [Abstract][Full Text] [Related]
12. Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia.
Lim SH; Anantharaman V; Teo WS; Chan YH
Resuscitation; 2009 May; 80(5):523-8. PubMed ID: 19261367
[TBL] [Abstract][Full Text] [Related]
13. Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring.
Karotsis AK; Symeonidis A; Mastorantonakis SE; Stergiou GS;
Clin Exp Hypertens; 2006 Oct; 28(7):655-62. PubMed ID: 17060064
[TBL] [Abstract][Full Text] [Related]
14. Calcium antagonists--assessment of side effects.
Thulin T
Scand J Prim Health Care Suppl; 1990; 1():81-4. PubMed ID: 2100370
[TBL] [Abstract][Full Text] [Related]
15. Calcium antagonists and alpha 2-adrenoceptors: possible role of extracellular calcium ions in alpha 2-adrenoceptor-mediated vasoconstriction.
van Zwieten PA; van Meel JC; Timmermans PB
J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S273-9. PubMed ID: 6184552
[TBL] [Abstract][Full Text] [Related]
16. The dose-dependent study of verapamil and diltiazem on spinal anesthesia in the rat.
Chen YW; Chu CC; Chen YC; Wang JJ; Hung CH
Neurosci Lett; 2010 Sep; 482(1):76-80. PubMed ID: 20633604
[TBL] [Abstract][Full Text] [Related]
17. Antidotes to lethal cocaine toxicity in the rat.
Trouvé R; Nahas GG
Arch Int Pharmacodyn Ther; 1990; 305():197-207. PubMed ID: 1978646
[TBL] [Abstract][Full Text] [Related]
18. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC
J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
[TBL] [Abstract][Full Text] [Related]
20. Combination of ACE inhibitors and calcium antagonists: a logical approach.
Ruschitzka FT; Noll G; Lüscher TF
J Cardiovasc Pharmacol; 1998; 31 Suppl 2():S5-16. PubMed ID: 9605596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]